skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2]; ;  [3];  [1]
  1. Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiao Tong University Health Science Center, Xi'an, Shaanxi 710061 (China)
  2. Department of Clinical Laboratory, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052 (China)
  3. College of Public Health and Henan Key Laboratory of Tumor Epidemiology, Zhengzhou University, Zhengzhou, Henan 450052 (China)

Highlights: • miR-155 and FGF2 is associated with esophageal cancer progression. • miR-155 in TAMs suppressed ECA109 cell proliferation, migration and invasion, as well as reduction in angiogenesis. • miR-155-reduced cell growth, migration and invasion of ECA109 cells is associated with FGF2 suppression. Esophageal cancer (EC) is one of the most common malignancies with high incidence and mortality. Tumor-associated macrophages (TAMs) in the tumor microenvironment have been linked to the accelerated tumor progression. MicroRNAs (miR) are 19–25 nucleotide-long, noncoding RNA molecules, functioning as modulators of gene expression, and mediate a variety of biological functions, including tumor growth. In the present study, the effects and molecular mechanism of miR-155 in TAMs isolated from EC were explored. The expression of miR-155 and fibroblast growth factor-2 (FGF2) in EC tissues and cell lines were analyzed using reverse transcription-quantitative PCR (qRT-PCR) and western blot assays. TAMs were also transfected with the described constructs. Following, the culture medium from TAMs was collected for further analysis. The released FGF2, and inflammatory cytokines were quantified using ELISA. The cell viability, migrated and invaded levels were calculated through Cell Counting kit-8 (CCK8), and transwell analysis. Moreover, human umbilical vein endothelial cells (HUVEC) vasculature formation was determined using matrigel angiogenesis analysis. The results indicated that miR-155 expression was decreased in EC tissues and cell lines, while FGF2 expression was increased in comparison to those in the normal control group. Moreover, miR-155 mimics transfection up-regulated tumor necrosis factor α (TNF-α), interleukin (IL)-12 and inducible nitric oxide synthase (iNOS), while down-regulated IL-10, Arginase-1 (Arg-1) and IL-22 levels in the culture medium from TAMs. And enhancing miR-155 expression in TAMs suppressed the cell viability, migration and invasion of ECA109 cells and reduced the angiogenesis. Nevertheless, over-expressing FGF2 abolished the role of miR-155 in cancer cell survival, migration, invasion as well as angiogenesis. Our findings indicated that miR-155-regulated FGF2 expression from TAMs suppressed EC cell proliferation, migration, invasion and inhibited vasculature formation. Thus, miR-155-modulated FGF2 might be a potential therapeutic target to prevent EC progression.

OSTI ID:
23105620
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 503, Issue 2; Other Information: Copyright (c) 2018 Published by Elsevier Inc.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer
Journal Article · Sat Apr 01 00:00:00 EDT 2017 · Biochemical and Biophysical Research Communications · OSTI ID:23105620

Overexpression of miR-133 decrease primary endothelial cells proliferation and migration via FGFR1 targeting
Journal Article · Wed Aug 15 00:00:00 EDT 2018 · Experimental Cell Research · OSTI ID:23105620

Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis
Journal Article · Fri Jan 15 00:00:00 EST 2016 · Experimental Cell Research · OSTI ID:23105620